What is the ticker symbol for Krystal Biotech?

Krystal Biotech trades under the ticker KRYS on NASDAQ.

What sector does Krystal Biotech operate in?

Krystal Biotech is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze KRYS in a portfolio?

PortView shows KRYS's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

Krystal Biotech (KRYS) Stock Analysis

NASDAQHealthcareBiotechnology

$368.27+1.22%

1-year price historyRange $137.46 – $378.15

52-week range$368.27

$136.73$382.54

What Krystal Biotech does

Krystal Biotech, Inc. is a clinical-stage biotechnology company focused on developing redosable gene therapies to address severe orphan diseases across the United States. Its most advanced therapeutic candidate, beremagene geperpavec (B-VEC), is currently undergoing Phase III clinical evaluation for the treatment of dystrophic epidermolysis bullosa. The company's pipeline also includes several other promising programs: KB105 is in Phase I/II clinical trials for patients suffering from deficient autosomal recessive congenital ichthyosis; KB301 is also in Phase I/II development, aiming to ameliorate wrinkles and other signs of aging or damaged skin. Additionally, Krystal Biotech is conducting preclinical research on KB407 for cystic fibrosis and KB104 for Netherton syndrome. In its earlier discovery phase, the company is exploring candidates such as KB5xx for chronic skin conditions and multiple KB3xx programs targeting aesthetic dermatological concerns. Krystal Biotech, Inc. was established in 2015 and is based in Pittsburgh, Pennsylvania.

Key metrics

Market cap

$10.86B

P/E (TTM)

46.15

EPS (TTM)

$7.98

Beta

0.54

Dividend yield

0.00%

Revenue / share

$14.92

50-day avg

$348.73

200-day avg

$287.91

52-week high

$382.54

52-week low

$136.73

CEO

Krish S. Krishnan

ETFs linked to KRYS

Broad-market and Healthcare sector ETFs an investor holding Krystal Biotech is often also exposed to. Open an ETF page to see its actual top holdings.

SPY — SPDR S&P 500 ETF Trust VOO — Vanguard S&P 500 ETF QQQ — Invesco QQQ Trust VTI — Vanguard Total Stock Market ETF

PortView Portfolio Insights

PortView analyzes how KRYS fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze KRYS in PortView →

Similar companies

JNJ — Johnson &LLY — Eli Lilly A — Agilent Technologies ABBV — AbbVie Inc.ABT — Abbott Laboratories ALNY — Alnylam Pharmaceuticals

Frequently asked questions

What is the ticker symbol for Krystal Biotech?: Krystal Biotech trades under the ticker KRYS on NASDAQ.
Which exchange is KRYS listed on?: KRYS is listed on NASDAQ.
What sector does Krystal Biotech operate in?: Krystal Biotech is classified in the Healthcare sector (Biotechnology industry).
How can PortView help analyze KRYS in a portfolio?: PortView shows KRYS's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.